ANTARES PHARMA INC's ticker is ATRS and the CUSIP is 036642106. A total of 120 filers reported holding ANTARES PHARMA INC in Q4 2018. The put-call ratio across all filers is 2.27 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $44,690,000 | +15.9% | 10,900,000 | +0.9% | 1.62% | -11.3% |
| Q4 2021 | $38,556,000 | +5.9% | 10,800,000 | +8.0% | 1.82% | +79.0% |
| Q3 2021 | $36,400,000 | -12.1% | 10,000,000 | +5.3% | 1.02% | -61.0% |
| Q2 2021 | $41,420,000 | +15.5% | 9,500,000 | +8.9% | 2.61% | +24.5% |
| Q1 2021 | $35,850,000 | +151.6% | 8,722,647 | +144.3% | 2.09% | +100.0% |
| Q4 2020 | $14,247,000 | +40605.7% | 3,570,563 | +27654.1% | 1.05% | +26075.0% |
| Q4 2018 | $35,000 | -96.7% | 12,865 | -96.0% | 0.00% | -95.8% |
| Q3 2017 | $1,050,000 | -89.8% | 324,076 | -89.8% | 0.10% | -95.5% |
| Q2 2017 | $10,267,000 | +52.4% | 3,188,600 | +34.4% | 2.12% | +7.9% |
| Q1 2017 | $6,736,000 | +148.3% | 2,371,970 | +103.7% | 1.96% | +110.4% |
| Q4 2016 | $2,713,000 | – | 1,164,348 | – | 0.93% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sargent Investment Group, LLC | 3,096,355 | $8,422,000 | 5.18% |
| JW Asset Management, LLC | 1,920,524 | $5,224,000 | 3.85% |
| Healthcare Value Capital, LLC | 250,000 | $680,000 | 2.64% |
| ARMISTICE CAPITAL, LLC | 10,300,000 | $28,016,000 | 2.12% |
| Broadfin Capital, LLC | 3,444,147 | $9,368,000 | 1.23% |
| PERKINS CAPITAL MANAGEMENT INC | 409,000 | $1,112,000 | 0.86% |
| MYCIO WEALTH PARTNERS, LLC | 1,896,500 | $5,158,000 | 0.48% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 1,012,600 | $2,754,000 | 0.22% |
| FALCON POINT CAPITAL, LLC | 130,200 | $354,000 | 0.21% |
| Brown Advisory Securities, LLC | 275,000 | $781,000 | 0.15% |